JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Synthesis and Anti-inflammatory Activity of [2-(Benzothiazol-2-ylimino)-4-oxo-3-phenylthiazolidin-5-yl]-acetic Acid Derivatives
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Synthesis and Anti-inflammatory Activity of [2-(Benzothiazol-2-ylimino)-4-oxo-3-phenylthiazolidin-5-yl]-acetic Acid Derivatives
Sushilkumar S. Bahekar; Devanand B. Shinde;
  PDF(new window)
 Abstract
A synthetic method for the title compounds (2a-o) was carried out. The title compounds (2a-o)were prepared by the condensation of various thioureas and maleic anhydride. Anti-inflammatory activities in vivo were evaluated and compared with standard drug diclofenac sodium. Some compounds showed moderate activity. The structures of all the new compounds were established on the basis of NMR and IR spectral data.
 Keywords
Anti-Inflammatory; Synthesis; [2-(Benzothiazol-2-ylimino)-4-oxo-3-phenylthiazolidin-5-yl]-acetic Acid; Thiazolidinylacetic Acid;
 Language
English
 Cited by
1.
Eco-Friendly Synthesis and Insecticidal Activity of Some Fluorinated 2-(N-Arylamino)-4-Arylthiazoles, Phosphorus, Sulfur, and Silicon and the Related Elements, 2010, 185, 7, 1321  crossref(new windwow)
2.
Synthesis and analgesic activity of some acetamide derivatives, Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, 27, 2, 275  crossref(new windwow)
3.
Synthesis and antimicrobial evaluation of novel 1,3-thiazoles and unsymmetrical azines, Research on Chemical Intermediates, 2016, 42, 4, 3333  crossref(new windwow)
4.
Synthesis, characterization, structural study and antibacterial activity of the Schiff bases derived from sulfanilamides and related copper(II) complexes, Inorganica Chimica Acta, 2016, 453, 238  crossref(new windwow)
 References
1.
Jury, P. F. In Chemistry and Pharmacology; Edited byR.A. Scherrer and M.W. Whitehouse Academic pressNew York, U. S. A., 1974; Vol. 1, p 92.

2.
Daniel, Lednicer; Lester A. Mitscher, In Organic Chemistry of Drug Synthesis, John Wiley and Sons,New York, U. S. A., 1980; Vol. 2, p 222.

3.
Andrisano M. G; Di Bella M; Ferrari P; Raffa L; BaggioG. G. Farmaco [Sci] 1981, 36(11), 905.

4.
Kentoro, H.; Hirohiko S. Chem. Pharm. Bull. 1977, 25,2292. crossref(new window)

5.
Sawhney, S. N.; Dhindsa, G. S.; Singh S. P. Indian J.Chemistry 1983, 22B, 1044.

6.
Om Parkash; Shobhna Saini; Neena Saini; Indra Prakash.;Shiv P. Singh; Indian J. Chemistry, 1975, 34(B), 660.

7.
Kocabalkanli A.; Ates O.; Otuk G. Arch Pharm (Weinheim)2001, 334(2), 35. crossref(new window)

8.
Capan G.; Ulusoy N.; Ergenc N.; Cevdet Ekinci A.;Vidin A. Farmaco. 1996, 51(11), 729.

9.
Ates O.; Kocabalkanli A.; Sanis G. O.; Ekinci A. C.; Vidin A. Arzneimittelforschung 1997, 47(10),1134.

10.
Abdel-Rahman R.M. Boll Chim Farm 2001, 140(6),401.

11.
Tripathi M.; Verma M.; Gujrati V. R.; Palit G.; ShankerK. Arzneimittelforschung 1993, 43(6), 632.

12.
Trivedi J. P.; Contractor S. J.; Shah I. D.; Jour. IndianChem. Soc. 1966, I, 265

13.
Winter, C. A.; Fisley, E. A.; Nuss, G. W. Proc. Soc.Exp. Biol. Med. 1962, 111, 544. crossref(new window)